{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T10:58:09Z","timestamp":1781953089742,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"MAT2011 (Ministry of Science and Innovation, Spain)","award":["26994"],"award-info":[{"award-number":["26994"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.ijpharm.2014.08.059","type":"journal-article","created":{"date-parts":[[2014,8,29]],"date-time":"2014-08-29T21:12:12Z","timestamp":1409346732000},"page":"208-213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Permeation studies through porcine small intestine of furosemide solutions for personalised paediatric administration"],"prefix":"10.1016","volume":"475","author":[{"given":"N.","family":"Provenza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.C.","family":"Calpena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Mallandrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Egea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6126-7890","authenticated-orcid":false,"given":"B.","family":"Clares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2014.08.059_bib0005","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijpharm.2004.05.011","article-title":"Development and in vitro evaluation of furosemide transdermal formulations using experimental design techniques","volume":"281","author":"Agyralides","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2014.08.059_bib0010","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1016\/j.clinthera.2008.11.015","article-title":"Dosage form design and development","volume":"30","author":"Allen","year":"2008","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ijpharm.2014.08.059_bib0015","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s11096-012-9670-y","article-title":"What\u2019s in a drop? Optimizing strategies for administration of drugs in pediatrics","volume":"4","author":"Bauters","year":"2012","journal-title":"Int. J. Clin. Pharm."},{"key":"10.1016\/j.ijpharm.2014.08.059_bib0020","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1085\/jgp.68.6.583","article-title":"Furosemide inhibition of chloride transport in human red blood cells","volume":"68","author":"Brazy","year":"1976","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.ijpharm.2014.08.059_bib0025","series-title":"The Merck Index: An Encyclopedia of Chemicals, Drugs and Biologicals","author":"Budavari","year":"1989"},{"key":"10.1016\/j.ijpharm.2014.08.059_bib0030","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0889-8553(21)00164-3","article-title":"Development of gastrointestinal motility in the infant and child","volume":"23","author":"Dumont","year":"1994","journal-title":"Gastroenterol. Clin. North Am."},{"key":"10.1016\/j.ijpharm.2014.08.059_bib0035","unstructured":"European Medicines Agency (EMA), 2006. http:\/\/ec.europa.eu\/health\/files\/eudralex\/vol-1\/reg20061901\/reg20061901en.pdf(accessed 28.07.14)."},{"key":"10.1016\/j.ijpharm.2014.08.059_bib0040","unstructured":"European Pharmacopoeia 7.0. http:\/\/www.edqm.eu\/en\/european-pharmacopoeia-publications-1401.html (accessed 25.07.14)."},{"key":"10.1016\/j.ijpharm.2014.08.059_bib0045","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.foodhyd.2005.08.008","article-title":"Viscosity and flavour perception: why is starch different from hydrocolloids?","volume":"20","author":"Ferry","year":"2006","journal-title":"Food Hydrocoll."},{"key":"10.1016\/j.ijpharm.2014.08.059_bib0050","series-title":"Principles of Medicinal Chemistry","author":"Foye","year":"1995"},{"key":"10.1016\/j.ijpharm.2014.08.059_bib0055","first-page":"336","article-title":"The use of a diuretic agent as a probe to investigate site and mechanism of ion transport process","volume":"35","author":"Giebisch","year":"1985","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ijpharm.2014.08.059_bib0060","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1002\/jps.22030","article-title":"Biowaiver monographs for immediate release solid oral dosage forms: furosemide","volume":"99","author":"Granero","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2014.08.059_bib0065","unstructured":"ICH, 2006. Validation of analytical procedures: text and methodology Q2 (R1), http:\/\/www.ema.europa.eu (accessed 28.07.14)."},{"key":"10.1016\/j.ijpharm.2014.08.059_bib0070","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jpba.2005.12.020","article-title":"Prediction of the permeability of drugs through study on quantitative structure\u2013permeability relationship","volume":"41","author":"Jung","year":"2006","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ijpharm.2014.08.059_bib0075","first-page":"1","article-title":"Formulation and evaluation of floating tablets of furosemide","volume":"1","author":"Karkhile","year":"2010","journal-title":"Int. J. Pharm. Res. Dev."},{"key":"10.1016\/j.ijpharm.2014.08.059_bib0080","series-title":"Physical Pharmacy","author":"Martin","year":"1993"},{"key":"10.1016\/j.ijpharm.2014.08.059_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.carbpol.2013.01.005","article-title":"Novel microparticulate systems for the vaginal delivery of nystatin: development and characterization","volume":"94","author":"Mart\u00edn-Villena","year":"2013","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijpharm.2014.08.059_bib0090","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1053\/jpsu.2001.21614","article-title":"Benefits of oral administration of an electrolyte solution interrupting a prolonged preoperatory fasting period in pediatric patients","volume":"36","author":"Moyao-Garc\u00eda","year":"2001","journal-title":"J. Ped. Surg."},{"key":"10.1016\/j.ijpharm.2014.08.059_bib0095","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/j.clinthera.2008.11.020","article-title":"Extemporaneous drug formulations","volume":"30","author":"Nahata","year":"2008","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ijpharm.2014.08.059_bib0100","series-title":"Pharmaceutical Dosage Forms: Disperses Systems","first-page":"247","article-title":"Reconstitutable oral suspensions","author":"Ofner","year":"1996"},{"key":"10.1016\/j.ijpharm.2014.08.059_bib0105","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ijpharm.2013.11.006","article-title":"Design and physicochemical stability studies of paediatric oral formulations of sildenafil","volume":"460","author":"Provenza","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2014.08.059_bib0110","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jfoodeng.2007.03.036","article-title":"Modelling colour changes during the caramelisation reaction","volume":"83","author":"Quintas","year":"2007","journal-title":"J. Food Eng."},{"key":"10.1016\/j.ijpharm.2014.08.059_bib0115","first-page":"68","article-title":"Stability of spironolactone in an extemporaneously prepared aqueous suspension: the importance of microbiological quality of compounded paediatric formulations","volume":"11","author":"Salgado","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2014.08.059_bib0120","series-title":"Development of the Gastrointestinal Tract","author":"Sanderson","year":"1999"},{"key":"10.1016\/j.ijpharm.2014.08.059_bib0125","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ijpharm.2011.11.034","article-title":"Design of a pediatric oral formulation with a low proportion of hydrochlorothiazide","volume":"423","author":"Santove\u00f1a","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2014.08.059_bib0130","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/jps.2600690533","article-title":"Effect of pH, chlorobutanol, cysteine hydrochloride, ethylenediaminetetraacetic acid, propylene glycol, sodium metabisulfite, and sodium sulfite on furosemide stability in aqueous solutions","volume":"69","author":"Shah","year":"1980","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2014.08.059_bib0135","first-page":"332","article-title":"Absorption and disposition of furosemide in healthy volunteers: measured with a metabolite-specific assay","volume":"5","author":"Smith","year":"1980","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ijpharm.2014.08.059_bib0140","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijpharm.2005.05.006","article-title":"Paediatric formulations-getting to the heart of the problem","volume":"300","author":"Standing","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2014.08.059_bib0145","first-page":"332","article-title":"Compounded preparations","volume":"1","author":"The United States Pharmacopeial Convention","year":"2007"},{"key":"10.1016\/j.ijpharm.2014.08.059_bib0150","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijpharm.2005.04.024","article-title":"The examination of polysaccharides as potential antioxidative compounds for topical administration using a lipid model system","volume":"298","author":"Trommer","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2014.08.059_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2125.2007.02987.x","article-title":"Off-label and unlicensed prescribing for children: have we made any progress?","volume":"64","author":"Waller","year":"2007","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijpharm.2014.08.059_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2010.11.001","article-title":"Oral drug delivery in personalized medicine: unmet needs and novel approaches","volume":"404","author":"Wening","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2014.08.059_bib0165","first-page":"71","article-title":"Extemporaneous compounding: a return to regulatory limbo?","volume":"16","author":"Winckler","year":"2002","journal-title":"J. Pain Palliat Care Pharmacother."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517314006255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517314006255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T23:47:05Z","timestamp":1650066425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517314006255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":33,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0378517314006255"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2014.08.059","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Permeation studies through porcine small intestine of furosemide solutions for personalised paediatric administration","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2014.08.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}